Cetuximab Bulk Active from Germany
Cetuximab targets EGFR for colorectal cancer treatment as monoclonal antibody. Unmixed form under HTS 3002.13.0090 as per immunological product notes. Biotechnologically produced.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• EGFR specificity assays required for validation
• Avoid animal facility imports without vet clearance
• pH stability critical for classification